AAAAAA

   
Results: 1-15 |
Results: 15
A PHASE-II STUDY OF ANTITUMOR EFFICACY AND SAFETY OF EXEMESTANE (EXE)AS 3RD-LINE HORMONAL TREATMENT OF POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER (MBC) REFRACTORY TO TAMOXIFEN AND MEGACE(TM)
Authors: JONES S VOGEL C FEHRENBACHER L EISENBERG P ARKHIPOV A TIFFANY J POLLI A WHALEY F DISALLE E MILLER L
Citation: S. Jones et al., A PHASE-II STUDY OF ANTITUMOR EFFICACY AND SAFETY OF EXEMESTANE (EXE)AS 3RD-LINE HORMONAL TREATMENT OF POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER (MBC) REFRACTORY TO TAMOXIFEN AND MEGACE(TM), Annals of oncology, 9, 1998, pp. 64-64
INTRATUMORAL CISPLATIN EPINEPHRINE INJECTABLE GEL - PALLIATIVE TREATMENT OF ADVANCED SOLID TUMORS/
Authors: FERNANDO I ORATZ R EISENBERG P CASTRO D LEAVITT R
Citation: I. Fernando et al., INTRATUMORAL CISPLATIN EPINEPHRINE INJECTABLE GEL - PALLIATIVE TREATMENT OF ADVANCED SOLID TUMORS/, Annals of oncology, 9, 1998, pp. 663-663
A COMPARISON OF ASPIRIN PLUS TIROFIBAN WITH ASPIRIN PLUS HEPARIN FOR UNSTABLE ANGINA
Authors: BAZZINO O AYLWARD P HAINS A SLANY J STEINBACH K VANDEWERF F VRINTS C COELHO O RAMIRES J BOGATY P BOUDREAULT J DIODATI J GOSSARD D KOUZ S LARAMEE P LEMAY M MAILLETTE S THEROUX P BOTERO R ARCE M HEIKKILA J DANCHIN D WEBER S KROMER EP NEUMANN FJ NIENABER C KATRITSIS D PAPAZAGLOU N BENHORIN J DAVID D TZIVONI D GUAZZI M MOGUEL R VERDEJO J BONNIER J DEZWAAN C HAMER AW WHITE HD AARONES M ARVESEN K FOSSUM E HENESTAM B ROLLAG A RIBEIRO V COMMERFORD P LANDLESS P MARX J WEICH H ANCILLO P CATURLA J CIVEIRA E FERRERO J FIGUERAS J GINESTAL R RUANO M ERHARDT L SYLVEN C LUSCHER T MOCCETTI T ADAMS P ADGEY AAJ BULLER N CANEPA R FURNISS S GREENBAUM R HALL J JENNINGS K KOONER J LEVY R LIPKIN D NOBLE M ROTHMAN M ABRAHAMSON D AGUIRRE F AMBROSE J ANDERSON HV ANDERSON J ARORA R BABB J BHASIN S BITTAR N BOTTI R BOWLES M BROWN A COHEN M COLFER H DALEY W DAWLEY D DETRANO R EISENBERG P FARHAT N FAXON D FREY M FRIEDMAN S GOLDSCHLAGER N GRADMAN A GUTIERREZ F HATTEMER C HERRMANN H HOCHMAN J ISRAEL N KIERNAN J KOREN M KRAMER J LING F MEHTA J MODY F MOHIUDDIN S NAFZIGER A NAIR R NIEDERMAN A PALABRICA T RODRIGUEZ S ROSENSON R RUTHERFORD J SCHMEDTJE J SHAH PK SHARMA S SMITH S SMITHERMAN T STILLABOWER M TIERSTEIN P VAUGHAN D WATERS D WEINSTOCK P WILLIAMS M YAKUBOV S ZOBLE R KLEIMAN NS LIPSCHUTZ KH SAX FL CAIRNS J ESPELAND M FITZGERALD G VERSTRAETE M WEAVER WD WILLIAMS DO DREIFUS LS NASMITH J RUNGE M GROSSMAN W SNAPINN SM BREMER M FRAME V HUTNYAN J LAPPE JT SERGIO M THORNTON A
Citation: O. Bazzino et al., A COMPARISON OF ASPIRIN PLUS TIROFIBAN WITH ASPIRIN PLUS HEPARIN FOR UNSTABLE ANGINA, The New England journal of medicine, 338(21), 1998, pp. 1498-1505
ANTITHROMBOTIC EFFECTS OF A NOVEL ANTAGONIST OF FACTOR XA
Authors: BAUM P LIGHT D VERHALLEN P SULLIVAN M EISENBERG P ABENDSCHEIN D
Citation: P. Baum et al., ANTITHROMBOTIC EFFECTS OF A NOVEL ANTAGONIST OF FACTOR XA, Circulation, 98(17), 1998, pp. 4193-4193
DEVELOPMENT OF A FLUDARABINE PHOSPHATE (FAMP) DOSING FORMULA IN PATIENTS WITH RENAL-INSUFFICIENCY BASED ON A PHARMACOKINETIC (PK) STUDY IN PATIENTS WITH AND WITHOUT RENAL IMPAIRMENT
Authors: LICHTMAN SM CASACELLA P BUDMAN DR WILLIAMS G EISENBERG P DAMICO P OMARA V MUSGRAVE K ETCUBANAS E
Citation: Sm. Lichtman et al., DEVELOPMENT OF A FLUDARABINE PHOSPHATE (FAMP) DOSING FORMULA IN PATIENTS WITH RENAL-INSUFFICIENCY BASED ON A PHARMACOKINETIC (PK) STUDY IN PATIENTS WITH AND WITHOUT RENAL IMPAIRMENT, British Journal of Haematology, 102(1), 1998, pp. 245-245
COAGULATION MARKERS AND OUTCOMES IN ACUTE CORONARY SYNDROMES
Authors: ARDISSINO D MERLINI PA EISENBERG P KOTTKEMARCHANT K CRENSHAW BS GRANGER CB
Citation: D. Ardissino et al., COAGULATION MARKERS AND OUTCOMES IN ACUTE CORONARY SYNDROMES, The American heart journal, 136(4), 1998, pp. 7-18
TISSUE FACTOR PATHWAY INHIBITOR ATTENUATES PROCOAGULANT ACTIVITY ON BALLOON-INJURED ARTERIES IN PIGS
Authors: PIERRE JS YANG LY TAMIRISA K EISENBERG P TOLUNAY E ABENDSCHEIN D
Citation: Js. Pierre et al., TISSUE FACTOR PATHWAY INHIBITOR ATTENUATES PROCOAGULANT ACTIVITY ON BALLOON-INJURED ARTERIES IN PIGS, Thrombosis and haemostasis, 1997, pp. 1665-1665
UNSATURATED POLYESTERS - INFLUENCE OF THE MOLAR-MASS ON THE CURE WITHSTYRENE AND THE PROPERTIES OF THE RESULTING NETWORKS
Authors: EISENBERG P LUCAS JC WILLIAMS RJJ
Citation: P. Eisenberg et al., UNSATURATED POLYESTERS - INFLUENCE OF THE MOLAR-MASS ON THE CURE WITHSTYRENE AND THE PROPERTIES OF THE RESULTING NETWORKS, Journal of applied polymer science, 65(4), 1997, pp. 755-760
ANTIEMETIC EFFICACY OF 2 DIFFERENT SINGLE INTRAVENOUS DOSES OF DOLASETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN-CONTAINING CHEMOTHERAPY
Authors: YEILDING A BERTOLI L EISENBERG P PLEZIA P MODIANO MR ALBERTS DS KHOJASTEH A CRAMER MB HAHNE WF
Citation: A. Yeilding et al., ANTIEMETIC EFFICACY OF 2 DIFFERENT SINGLE INTRAVENOUS DOSES OF DOLASETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN-CONTAINING CHEMOTHERAPY, American journal of clinical oncology, 19(6), 1996, pp. 619-623
RESULTS OF THE ECONOMIC-EVALUATION OF THE FIRST STUDY - A MULTINATIONAL PROSPECTIVE ECONOMIC-EVALUATION
Authors: SCHULMAN KA BUXTON M GLICK H SCULPHER M GUZMAN G KONG J BACKHOUSE M MAUSKOPF J BELL L EISENBERG JM CALIFF RM MCKENNA WJ HARRELL FE URETSKY BF ADAMS KF SWEDBERG KB GHEORGHIADE M ZANNAD F HANDBERG E DARIUS H SOLERSOLER J WHEELER WS ARMSTRONG PW PATTERSON H MURALI S BUTMAN S KIRLIN PC MILLER LW JAFRI S RICH S COSTANZONORDIN MR MCGOON M HOSENPUD JD RATKOVEC R BRUNDAGE B PRITZKER M BOURGE R REEVES W FORGOSH L VENTURA H YOUNG JB MANCINI D MILLS RM LIMACHER MC LEE F REVKIN J KALBFLEISCH JM FISHBEIN D PRESSLER M HAEUSSLEIN E KARLSBERG RP OCONNELL J LEJEMTEL TH THOMAS HM SMITH WB MCIVOR M CINTRON GB HAGER WD MESSINEO FC DOUGHERTY JE HASSAPOYANNES C HOOD W MCGREW F SANFORD CF OCONNER CM HOBBS RE YARDLEY D KAY R MINOTTI J EASTBURN TE LINDENFELD J LITMAN G WICKEMEYER W HORTON S GILBERT EM EICHORN E RIBNER HS CORDER C PHILBIN E NOCERO M ELKAYAM U JESSUP M CRAWFORD M CARSON P REDDY HK KLAPHOLZ M HEYWOOD JT SALINGER M KARLSBERG R BUSH D HUNTER C WOHNS D EISENBERG P WINSTON S BUTCHER C MASSIN E WYNNE J TONKON M SPACCAVENTO L DIVER D GHALI J HUTCHINS S ANAND I BEANLANDS D KOSTUK W PFLUGFELDER P LANGLEBEN D LATOUR P MIZGALA H RICCI D MANYARI D DARGIE HJ DAVIDSON C SWANTON H HUBNER PJB OAKLEY D BROOKS N JENNINGS K GREENBAUM RA PENNY WJ NICHOLLS P WALSH M SUGRUE D FENNELL W HORGAN JH JONDEAU G CASTAIGNE A LEMAREC H WALGER P PARK JW DEBERRAZUETA JR MOL MG SANCHEZ MAG CAPONNETTO S MAGNANI B GALIE N DEVITA C MASERI A BAGGER JP REMES J WALDENSTROM A SCHAUFELBERGER M DIENSTI F SIMOONS ML KLEIN W PACHER R KEOGH A HARLEY A
Citation: Ka. Schulman et al., RESULTS OF THE ECONOMIC-EVALUATION OF THE FIRST STUDY - A MULTINATIONAL PROSPECTIVE ECONOMIC-EVALUATION, International journal of technology assessment in health care, 12(4), 1996, pp. 698-713
RESTORING PUBLIC TRUST IN NONPROFITS AND GOVERNMENTS
Authors: EISENBERG P
Citation: P. Eisenberg, RESTORING PUBLIC TRUST IN NONPROFITS AND GOVERNMENTS, Harvard business review, 74(3), 1996, pp. 166
PHASE-II TRIAL OF DOCETAXEL IN ADVANCED ANTHRACYCLINE-RESISTANT OR ANTHRACENEDIONE-RESISTANT BREAST-CANCER
Authors: RAVDIN PM BURRIS HA COOK G EISENBERG P KANE M BIERMAN WA MORTIMER J GENEVOIS E BELLET RE
Citation: Pm. Ravdin et al., PHASE-II TRIAL OF DOCETAXEL IN ADVANCED ANTHRACYCLINE-RESISTANT OR ANTHRACENEDIONE-RESISTANT BREAST-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2879-2885
SUFFIX REANALYSIS AND SYLLABICATION, THE RELATION BETWEEN PHONOLOGICAL AND MORPHOLOGICAL SEGMENTATION
Authors: EISENBERG P
Citation: P. Eisenberg, SUFFIX REANALYSIS AND SYLLABICATION, THE RELATION BETWEEN PHONOLOGICAL AND MORPHOLOGICAL SEGMENTATION, Folia linguistica historica, 13(1-2), 1993, pp. 93-113
AMONAFIDE TREATMENT OF REFRACTORY ESOPHAGEAL CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: POPLIN E FLEMING T MACDONALD JS EISENBERG P FISHER RI CONRAD ME
Citation: E. Poplin et al., AMONAFIDE TREATMENT OF REFRACTORY ESOPHAGEAL CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Investigational new drugs, 11(1), 1993, pp. 47-51
COMPARATIVE EFFECTS OF HEPARIN AND HIRUDIN ON FIBRINOLYTIC AND THROMBOTIC ACTIVITIES DURING TISSUE-TYPE PLASMINOGEN-ACTIVATOR THERAPY
Authors: LOSCALZO J ABDENSCHEIN D EISENBERG P BECKER R GEORGE D MCCABE C SOBEL B BRAUNWALD E
Citation: J. Loscalzo et al., COMPARATIVE EFFECTS OF HEPARIN AND HIRUDIN ON FIBRINOLYTIC AND THROMBOTIC ACTIVITIES DURING TISSUE-TYPE PLASMINOGEN-ACTIVATOR THERAPY, Circulation, 88(4), 1993, pp. 200-200
Risultati: 1-15 |